by Harvey Mogojwe | Sep 13, 2021
September 13, 2021 – Development is underway based on an agreement launched in June 2021 between Unitaid, the Clinton Health Access Initiative (CHAI), and pharmaceutical manufacturer Laurus Labs to accelerate the development, commercialization, and registration of the...
by Harvey Mogojwe | Sep 1, 2021
For every thousand children born in Zambia, 61 will die before their fifth birthday – almost twice the global rate. The leading causes of death include pre-term birth complications, birth asphyxia and trauma, pneumonia, congenital anomalies, diarrhea, and malaria, all...
by Harvey Mogojwe | Aug 5, 2021
TB program point-of-care testing was leveraged for HIV viral load and early infant diagnosis testing. Many national testing and treatment programs have traditionally been “vertical” in nature – focused on one disease alone – and have relied on processing tests in...
by Harvey Mogojwe | Aug 3, 2021
In 2011, the HPTN 052 trial demonstrated that people living with HIV who initiated treatment earlier – also referred to as early access to antiretroviral therapy (ART) for all – were less likely to transmit the virus to partners. Adoption of this approach meant that...
by Harvey Mogojwe | Jul 27, 2021
Hepatitis C (HCV) affects more than 58 million people worldwide, and a significant number of people with the disease will progress to chronic disease, liver cancer, and death. Although HCV is curable in more than 95 percent of patients with direct-acting antivirals...
